TLR7 and neoplasm: In addition, the TLR7/8 agonist imiquimod (IMDQ) conjugated to nanobodies regulates the mannose receptor (MR) and induces M1-like repolarization of alveolar macrophages, which obviously suppresses tumor progression (82).